The practical problems of prednisone in pediatric renal transplantation.
Ettenger
R
R
Mattel Children's Hospital at UCLA, Los Angeles, California, USA.
D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002908:Chronic Disease; D016572:Cyclosporine / Q000008:administration & dosage; D005919:Glomerular Filtration Rate / Q000187:drug effects / Q000502:physiology; D006084:Graft Rejection / Q000139:chemically induced* / Q000517:prevention & control; D006130:Growth Disorders / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016030:Kidney Transplantation; D016853:Muromonab-CD3 / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D011241:Prednisone; D016559:Tacrolimus